ReleaseWire

Harvard University educated archaeologist, current president of the applied archaeology firm, PRC, Inc., non-profit Ararat Conservation, Inc., and former maritime executive, Joel Klenck, reports, "It is 100% certain that a prehistoric site is Noah's Ark, located in the southern gorge of greater Mount Ararat and dating to an interval within the Late Epipaleolithic period (13,100-9,600 BC). This site exhibits all traits of an ancient Trot-on / Trot-off maritime barge, being unlike all terrestrial structures."

Harvard University educated archaeologist, current president of the applied archaeology firm, PRC, Inc., non-profit Ararat Conservation, Inc., and former maritime executive, Joel Klenck, reports, "It is 100% certain that a prehistoric site is Noah's Ark, located in the southern gorge of greater Mount Ararat and dating to an interval within the Late Epipaleolithic period (13,100-9,600 BC). This site exhibits all traits of an ancient Trot-on / Trot-off maritime barge, being unlike all terrestrial structures."

UK scientists testing fertility treatments abroad have discovered that "in vitro fertilization" success rates will increase when IVF treatment is carried out while on a Mediterranean style diet. Scientists are currently studying the quality of the sperm, the egg cells, the resulting embryo, as well as the environment in the uterus. Professor Nick Macklon, a consultant in obstetrics and gynaecology at Southampton's Princess Anne Hospital confirmed that current research did advise that a Mediterranean diet rich in vitamin D and omega-3 could boost IVF success rates, but that the idea had not yet been tested through an appropriate randomized trial.

When garcinia cambogia hit the market a few years back, people were curious about one thing – the odd sounding name. This name is no attempt to confuse the people or to create any sort of curiosity as it did among the people. The name is derived from a fruit called by the same name. The supplement itself is extracted from this fruit. From the very ancient time, natives were aware of the weight losing potential of this fruit and were used likewise in its natural form.

Increasing pressure on emergency services in the region has made the implementation of strategies to streamline multi-agency response to emergencies, and to more effectively coordinate disaster management, absolutely necessary. This year, for the first time, the Middle East Emergency Medicine Exhibition and Conference will be held alongside the 6th edition of Hospital Build & Infrastructure Middle East in Dubai, UAE, from 2-4 June 2014 at the Dubai International Convention & Exhibition Centre.

Approximately 10 million Americans and more than 100 million people all over the world suffer from lymphedema. It is a painful and chronic swelling of the lymph nodes which may possibly have an impact on as much as 70 percent of women who have surgery or received chemotherapy for breast cancer. Men who have went have underwent prostate cancer surgery may experience it as well.

Liposuction choices in 2014 and the background to the changes in technology used for liposuction are the subject of the latest educational video from Edmonton cosmetic dermatologist Dr Barry Lycka.

A number of biologics will lose patent protection between now and 2015, which means that France's biosimilar substitution legislation will pave the way to cost savings in the healthcare system. However, we question the strength of this legislation, as development and manufacturing costs for these products are high and therefore actual cost savings secured through biosimilars may ultimately be limited. Furthermore, ongoing safety concerns may act as a barrier to the prescription of biosimilars

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - South Korea". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in South Korea. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts. In 2013, South Korea's population was approximately at 50.2 million. It has one of the world's highest population densities. The South Korean government has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growth. To support this industry, the South Korean regulatory authorities recently made changes to the regulatory bodies overseeing the pharmaceutical and wider medical sectors, to provide a transparent, strong and efficient regulatory system to facilitate faster approval of pharmaceutical products and medical devices. The South Korean pharmaceutical market is one of the largest in Asia, estimated to be worth $18.6 billion in 2013 and expected to reach $24.3 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.9% over the 2008-2020 period. The medical device market was valued at $3.3 billion in 2008 and is expected to reach approximately $6.3 billion by 2020, at a projected CAGR of 5.5%. These positive trends can primarily be attributed to:

Global Markets Direct's, 'Chronic Heart Failure - Pipeline Review, H1 2014', provides an overview of the Chronic Heart Failure's therapeutic pipeline.

Global Markets Direct's, 'Vectura Group plc - Product Pipeline Review - 2014', provides an overview of the Vectura Group plc's pharmaceutical research and development focus.

Global Markets Direct's, 'Systemic Lupus Erythematosus - Pipeline Review, H1 2014', provides an overview of the Systemic Lupus Erythematosus's therapeutic pipeline.

GlobalData's clinical trial report, "Germinomatous (Seminomatous) Germ Cell Tumors Global Clinical Trials Review, H1, 2014" provides data on the Germinomatous (Seminomatous) Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germinomatous (Seminomatous) Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germinomatous (Seminomatous) Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Leiomyosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Leiomyosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leiomyosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leiomyosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Arromax Pharmatech, Co. Ltd. - Product Pipeline Review - 2014', provides an overview of the Arromax Pharmatech, Co. Ltd.'s pharmaceutical research and development focus.

GlobalData's clinical trial report, "Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014" provides data on the Nasopharyngeal Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Nasopharyngeal Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014', provides an overview of the Gastrointestinal Stromal Tumor (GIST)'s therapeutic pipeline.

Global Markets Direct's, 'Chronos Therapeutics Limited - Product Pipeline Review - 2014', provides an overview of the Chronos Therapeutics Limited's pharmaceutical research and development focus.

GlobalData's clinical trial report, "Low-Grade Glioma Global Clinical Trials Review, H1, 2014" provides data on the Low-Grade Glioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Low-Grade Glioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Low-Grade Glioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Malignant Mesothelioma Global Clinical Trials Review, H1, 2014" provides data on the Malignant Mesothelioma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malignant Mesothelioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malignant Mesothelioma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's clinical trial report, "Scabies Global Clinical Trials Review, H1, 2014" provides data on the Scabies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Scabies. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Scabies. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Global Markets Direct's, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2014', provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)'s therapeutic pipeline.

Combining his knowledge of wind instrument playing and dentistry allows Dr. Lambert to offer a service that simply cannot be found in other dental practices. Musicians have very specialized needs when they use their mouths to play a musical instrument. The smallest change in a bite, tooth or jaw position, tooth shape, or tongue movement can significantly impact how a musician can play, and the dentist must understand and pay special attention to these problems. A trumpet player with a chipped front tooth can have the tooth restored with composite bonding to make it look great from a cosmetic standpoint but might ruin his playing career. A horn player may get beautiful porcelain veneers that may add half a millimeter to the length of the teeth but may wipe out the musician’s ability to play really high notes in his upper range. Even wind players with removable dentures may experience problems with range, sound quality, and air pressure or airflow issues into their horn.

As the category creator and world leader in healthy chocolate, the true vision of Xoçai is to transform and improve individual lives worldwide through its exclusive and healthy chocolate products. One such unique element is XoVita™, a proprietary high-antioxidant blend of cacao, açaí berries and blueberries, an ingredient combination exclusive to Xoçai. This proprietary and exclusive high-antioxidant blend is utilized in all of Xoçai products and provides a wide-ranging class of nutrients, vitamins and health benefits. XoVita™ consistently contributes to the findings that all of Xocai’s products contain the highest ORAC (antioxidant-measuring test) and flavonoid rich products available today. (mxicorp.com/xovita/)

As the category creator and world leader in healthy chocolate, the true vision of Xoçai is to transform and improve individual lives worldwide through its exclusive and healthy chocolate products. One such unique element is XoVita™, a proprietary high-antioxidant blend of cacao, açaí berries and blueberries, an ingredient combination exclusive to Xoçai. This proprietary and exclusive high-antioxidant blend is utilized in all of Xoçai products and provides a wide-ranging class of nutrients, vitamins and health benefits. XoVita™ consistently contributes to the findings that all of Xocai’s products contain the highest ORAC (antioxidant-measuring test) and flavonoid rich products available today. (mxicorp.com/xovita/)

No matter race, religion or politics, everyone has skin. And with that ubiquity comes a host of common issues, with everyone being dissatisfied with their skin at some point in their lives. From skin conditions to hormones to greasy food, all kinds of things can impact the skin, not to mention the ravages of the weather and carbon emissions. As such, people need to maintain their skin, and Easy Skin aims to make that process easy by publishing high quality editorials on products and ideas.

Weight loss supplements have been rampant all over the world for many years now, yet the proven effects of any brand in particular have not yet been discovered. As many weight loss supplements, techniques, and methods as there are, there still isn’t one that can successfully effect in weight loss no matter who takes it. This hereby means that there isn’t a set supplement compatible with everyone. It might be thought that with all the research done, all the new labs open, and all the pharmaceutical manufacturers, there might be at least ‘one size fits all’ supplement for the every growing problem of an increased weight.